Earlier this year the Hong Kong Stock Exchange (HKEX) updated its listing regime to include biotech companies. To accommodate their unique status as an emerging industry, the HKEX does not require them to demonstrate a record of profitability, but a special advisory panel assesses each listing.
For biotech companies considering a public debut on the HKEX, here are three top tips to help ensure a successful IPO. To learn more about how Tricor can help your company throughout a listing process, please contact one of our experts.
For more information, please download our Tricor Perspectives Series and contact us at (852) 2980 1779 or schedule a call with our expert team.